"Real-world" effectiveness of methylphenidate in improving the academic achievement of Attention-Deficit Hyperactivity Disorder diagnosed students-A systematic review
- PMID: 34254328
- DOI: 10.1111/jcpt.13486
"Real-world" effectiveness of methylphenidate in improving the academic achievement of Attention-Deficit Hyperactivity Disorder diagnosed students-A systematic review
Abstract
What is known and objective: Attention-deficit hyperactivity disorder (ADHD) symptoms usually impairs academic achievement and can trigger the onset of medication. Methylphenidate is a drug widely prescribed to treat ADHD. However, systematic reviews of randomized clinical trials suggest that it does not lead to great improvements in academic performance. Thus, we aimed to evaluate the evidence on the "real-world" effectiveness of methylphenidate in improving the academic achievement of ADHD students.
Methods: We conducted a systematic review of observational studies retrieved from five electronic databases, besides a manual search and search in grey literature. Studies evaluating treatment with methylphenidate compared to no treatment or other pharmacological/non-pharmacological alternatives used in ADHD were included. The risk of bias of the selected studies was assessed using adapted versions of the Newcastle-Ottawa Scale.
Results and discussion: Nine studies (from ten reports) were included in the review: four cohorts, two before-and-after designs and three cross-sectional studies. They involved 12,269 children and adolescents aged 6-18 years. The doses of methylphenidate ranged from 10 to 72 mg/day, and the duration of the treatment from 2.6 months to 4.25 years. Five of these studies concluded that methylphenidate improves academic performance. However, three of the four lowest-bias risk studies concluded that the drug is ineffective. Five studies assessed the long-term use of methylphenidate, and four of them concluded that it does not result in better outcomes in the school setting. Most included studies had considerable limitations and significant heterogeneity regarding methodological design and academic performance measurement criteria.
What is new and conclusion: Although some studies indicate that the short-term use of methylphenidate may improve outcomes in the school environment, the available evidence does not support the establishment of adequate conclusions about the real benefits of methylphenidate in the academic improvement of ADHD students.
Keywords: ADHD; Attention-deficit disorder with hyperactivity; academic performance; effectiveness; methylphenidate; systematic review.
© 2021 John Wiley & Sons Ltd.
Similar articles
-
Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.JAMA. 1998 Apr 8;279(14):1100-7. doi: 10.1001/jama.279.14.1100. JAMA. 1998. PMID: 9546570 Review.
-
Treatment of attention-deficit/hyperactivity disorder.Evid Rep Technol Assess (Summ). 1999 Nov;(11):i-viii, 1-341. Evid Rep Technol Assess (Summ). 1999. PMID: 10790990 Free PMC article.
-
Mood and Proneness to Boredom Are Associated with Poorer Continuous Performance Test Results, Which May Improve with Methylphenidate Treatment, in Attention-Deficit/Hyperactivity Disorder.J Child Adolesc Psychopharmacol. 2021 May;31(4):310-314. doi: 10.1089/cap.2021.0001. Epub 2021 May 5. J Child Adolesc Psychopharmacol. 2021. PMID: 33956509
-
Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder: a systematic review and meta-analyses.BMJ Open. 2019 Mar 30;9(3):e026478. doi: 10.1136/bmjopen-2018-026478. BMJ Open. 2019. PMID: 30928951 Free PMC article.
-
Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.J Child Psychol Psychiatry. 2021 Jun;62(6):680-700. doi: 10.1111/jcpp.13305. Epub 2020 Aug 26. J Child Psychol Psychiatry. 2021. PMID: 32845025
Cited by
-
One-year follow-up of the effectiveness and mediators of cognitive behavioural therapy among adults with attention-deficit/hyperactivity disorder: secondary outcomes of a randomised controlled trial.BMC Psychiatry. 2024 Mar 16;24(1):207. doi: 10.1186/s12888-024-05673-8. BMC Psychiatry. 2024. PMID: 38491411 Free PMC article. Clinical Trial.
-
Methylphenidate (Ritalin) does not improve exam performance in an experimental setting.Psychopharmacology (Berl). 2025 Aug 5. doi: 10.1007/s00213-025-06864-1. Online ahead of print. Psychopharmacology (Berl). 2025. PMID: 40762809
-
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD012857. doi: 10.1002/14651858.CD012857.pub2. Cochrane Database Syst Rev. 2022. PMID: 35201607 Free PMC article.
-
Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship: A Retrospective Clinical Case Series.Children (Basel). 2024 Feb 2;11(2):187. doi: 10.3390/children11020187. Children (Basel). 2024. PMID: 38397299 Free PMC article.
References
REFERENCES
-
- American Psychiatric Association. DSM-5: Manual Diagnóstico e Estatístico de Transtornos Mentais. Porto Alegre: Artmed Editora; 2014:992 p.
-
- Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994-e1001.
-
- Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194(3):204-211.
-
- Baweja R, Mattison RE, Waxmonsky JG. Impact of attention-deficit hyperactivity disorder on school performance: what are the effects of medication? Paediatr Drugs. 2015;17(6):459-477.
-
- National Collaborating Centre for Mental Health (NCCMH). National Institute for Health and Clinical Excellence: Guidance. Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. Leicester (UK): The British Psychological Society & The Royal College of Psychiatrists; 2009.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical